- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Stellar Pharmaceuticals
Total 21050 results
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.CompletedSolid TumorsUnited States, Japan, Korea, Republic of, Taiwan
-
Astellas Pharma Singapore Pte. Ltd.CompletedInvasive Fungal InfectionsHong Kong, Korea, Republic of, Singapore, Taiwan, Thailand
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Institute for Regenerative MedicineWithdrawnAge-Related Macular DegenerationUnited States
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | PK for FG-4592Germany
-
Astellas Pharma Europe B.V.FibroGenCompletedHepatic Insufficiency | Healthy Subjects | PK of FG-4592Bulgaria
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncRecruiting
-
Astellas Pharma IncRecruiting
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia | FLT3-mutated Acute Myeloid LeukemiaJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDe Novo Kidney Transplant PatientsChina
-
Astellas Pharma IncCompletedBenign Prostate HyperplasiaJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDepression | Bipolar DisorderJapan
-
Astellas Pharma IncCompletedRheumatoid ArthritisJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAnemia | Hemodialysis | Renal ImpairmentJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP015KJapan
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedRheumatoid ArthritisUnited States
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States, India, Philippines, Colombia, Mexico
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedChronic ConstipationJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
Astellas Pharma IncCompletedChronic Kidney Disease | Hyperphosphatemia Undergoing HemodialysisJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Astellas Pharma IncCompletedDiarrhea-predominant Irritable Bowel SyndromeJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
Astellas Pharma IncCompletedUrinary IncontinenceUnited States, Canada